ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Auto-immunity"

  • Abstract Number: 1672 • 2012 ACR/ARHP Annual Meeting

    Myosin Skews Effector Immune Cells of Scurfy Mice to Target Muscles in an Adoptive Transfer Model of Myositis

    Nicholas Young1, Rahul Sharma2, Alexandra Friedman3, Benjamin Kaffenberger1 and Wael N. Jarjour4, 1Immunology and Rheumatology, The Ohio State University Medical Center, Columbus, OH, 2Medicine, University of Virginia Health System, Charlottesville, VA, 3Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 4Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: Myositis is associated with an inflammatory process that results in pronounced muscle weakness and is observed in some regulatory T cell (Treg) deficient mouse…
  • Abstract Number: 1649 • 2012 ACR/ARHP Annual Meeting

    French Cohort Study of 141 Cases of Autoimmune Congenital Heart Block

    Kateri Levesque1, Alice Maltret2, Mohamed Hamidou3, Moez Jallouli4, Jean Loup Pennaforte5, Pauline Orquevaux5, Jean-Charles Piette6, Zahir Amoura4, Francois Barriere7, Jérome Le Bidois2, Laurent Fermont2, Laurence Cohen8, Olivier Meyer9, Olivier Fain10, Arnaud Theulin11, Hugues Lucron12, Francois Sassolas13, Holly Bezanahary14, Gaëlle Guettrot-Imbert15, Pascal Seve16, Elizabeth Diot17, Nathalie Morel1, Christophe Deligny18, Elisabeth Villain2 and Nathalie Costedoat-Chalumeau19, 1Internal Medicine, Groupe Hospitalier Pitié-Salpétrière, Paris, France, 2Cardiology, Groupe Hospitalier Necker - Enfants Malades, Paris, France, 3Internal Medicine Department, Nantes University Hospital, Nantes, France, 4Department of Internal Medicine 2. Referal center for SLE/APS, CHU Pitié-Salpêtrière, Paris, France, 5Hu Robert Debre, CHU Reims, Reims, France, 6Hospital Pitie, Paris, 7Pediatry, CHU Nantes, Nantes, France, 8Cardiology, Institut Jacques Cartier, 9Rheumatology, Hopital Bichat, Paris, France, 10Internal Medicine, Service de médecine interne, Université Paris 13, AP-HP, Hôpital Jean Verdier, Bondy, France, 11Rheumatology, Strasbourg University Hospital, Strasbourg, France, 12Cardiology, CHU Fort-de-France, Fort de France, Martinique, 13Cardiology, CHU Lyon, Lyon, France, 14Internal Medicine, University Hospital of Limoges, Limoges, France, 15Internal Medicine, Hopital Gabriel Montpied, Clermont-Ferrand, France, 16Internal medicine, CHU Lyon, Lyon, France, 17Department of Internal Medicine, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire de Tours, Tours, France, Tours, France, 18Rhumatologie Et Médecine Interne, Centre hospitalier Universitaire de Fort de France, Fort de France, Martinique, 19Internal Medicine, Assistance Publique-Hôpitaux de Paris, Hopital Pitié-Salpétrière, Paris, France

    Background/Purpose: Cardiac neonatal lupus manifestations mainly include congenital heart block (CHB), endocardial fibroelastosis and dilated cardiomyopathy.  We report the preliminary results of the French registry…
  • Abstract Number: 1072 • 2012 ACR/ARHP Annual Meeting

    Enzymatic Lipid Oxidation Contributes to the Maintenance of Self-Tolerance by Regulating Antigen Clearance and Dendritic Cell Function

    Stefan Uderhardt1, Tobias Rothe1, Elisabeth Zinser2, Olga Oskolkova3, Martin Herrmann4, Alexander Steinkasserer5, Valery Bochkov3, Georg Schett6 and Gerhard Kronke1, 1Internal Medicine 3, University of Erlangen, Erlangen, Germany, 2University of Erlangen, Erlangen, Germany, 3Department of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria, Vienna, Austria, 4Instiute for Immunology, PhD, Erlangen, Germany, 5Department of Immune Modulation at the Department of Dermatology, University Hospital Erlangen, Erlangen, Germany, 6Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany

    Background/Purpose: During inflammation and tissue damage, pathogens as well as dying cells are ingested by different phagocytes such as macrophages and dendritic cells. The uptake…
  • Abstract Number: 979 • 2012 ACR/ARHP Annual Meeting

    Cell-Type Specific Type I Interferon Signatures in Systemic Lupus Erythematosus and Viral Infection: What Makes the Difference?

    Chieko Kyogoku1, Joachim R. Grün1, Tobias Alexander2, Robert Biesen3, Falk Hiepe4, Thomas Häupl3, Andreas Radbruch1 and Andreas Grützkau1, 1German Rheumatism Research Centre Berlin (DRFZ), an institute of the Leibniz Association, Berlin, Germany, 2Department of Rheumatology and Clinical Immunology, Charité – University Hospital, Berlin, Germany, 3department of Rheumatology and Clinical Immunology, Charité University Hospital Berlin, Berlin, Germany, 4Med. Klinik m. Sp. Rheumatologie und klin. Immunologie, Charité University Hospital Berlin, Berlin, Germany

    Background/Purpose: Gene expression profiling experiments using peripheral blood mononuclear cells (PBMCs) revealed a crucial role of type I interferon (IFN) in the pathogenesis of systemic…
  • Abstract Number: 685 • 2012 ACR/ARHP Annual Meeting

    Using a Library of Synthetic Autoantigen Mimics to Discover Biomarkers of Systemic Lupus Erythematosus

    Akshai Lakhanpal1, Jiexia Quan2, Sayed Zaman1, Nancy J. Olsen3 and David R. Karp2, 1Rheumatic Diseases Divsion, UT Southwestern Medical Center, Dallas, TX, 2Rheumatic Diseases Division, UT Southwestern Medical Center, Dallas, TX, 3Medicine, Penn State MS Hershey Medical Center, Hershey, PA

    Background/Purpose:   The natural history of systemic lupus erythematosus (SLE) is felt to evolve from a state of normal immunity to serologic autoimmunity and then…
  • Abstract Number: 686 • 2012 ACR/ARHP Annual Meeting

    Cell-Type Specific Type I Interferon Signatures in Autologous Stem Cell Transplanted Lupus Patients: Different Molecular Behavior Between CD4+ T Cells and Monocytes

    Chieko Kyogoku1, Joachim R. Grün1, Tobias Alexander2, Robert Biesen3, Falk Hiepe4, Thomas Häupl3, Andreas Radbruch1 and Andreas Grützkau1, 1German Rheumatism Research Centre Berlin (DRFZ), an institute of the Leibniz Association, Berlin, Germany, 2Department of Rheumatology and Clinical Immunology, Charité – University Hospital, Berlin, Germany, 3department of Rheumatology and Clinical Immunology, Charité University Hospital Berlin, Berlin, Germany, 4Med. Klinik m. Sp. Rheumatologie und klin. Immunologie, Charité University Hospital Berlin, Berlin, Germany

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease that affects multiple organs, whose pathology is mainly caused by the augmented interferon (IFN)…
  • Abstract Number: 670 • 2012 ACR/ARHP Annual Meeting

    Prolidase Deficiency Induces Antibodies to Sm, Ro60 and Double Stranded DNA

    Biji T. Kurien1, Anil D'souza2, Skyler P. Dillon1, Benjamin F. Bruner3, Timothy Gross4, Judith A. James5, Ira N. Targoff6, Jacen S. Maier-Moore7, Isaac T.W. Harley8, Heng Wang9 and Robert H. Scofield7, 1Department of Medicine, Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation; Department of Medicine, University of Oklahoma Health Sciences Center; US Department of Veterans Affairs Medical Center, Oklahoma City, OK, 2Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Harding University, Searcy, AR, 4Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Arthritis and Immunology, Oklahoma Medical Research Foun, Oklahoma City, OK, 7Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation; Department of Medicine, University of Oklahoma Health Sciences Center; US Department of Veterans Affairs Medical Center, Oklahoma City, OK, 8Cincinnati Children's Hospital Research Foundation, Cincinnati, OH, 9Das Deutsch Center Clinic for Special Needs Children, Middlefield, OH

    Background/Purpose: Prolidase is a ubiquitous enzyme found in the cytoplasm.  The enzyme specifically cleaves dipeptides containing C-terminal proline or hydroxyproline, in one of the last…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology